IL-33 exacerbates antigen-induced arthritis by activating mast cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 31, 2008, Pages 10913-10918

  Xu, Damo ^a   Jiang, Hui Rong ^a   Kewin, Peter ^a   Li, Yubin ^a   Mu, Rong ^a   Fraser, Alasdair R ^a   Pitman, Nick ^a   Kurowska Stolarska, Mariola ^a   McKenzie, Andrew N J ^b   McInnes, Iain B ^a   Liew, Foo Y ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Rheumatoid arthritis; ST2

Indexed keywords

COLLAGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 33; PROTEIN ST2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE EXACERBATION; FIBROBLAST; HUMAN; IN VITRO STUDY; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERLEUKINS; MAST CELLS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; STATISTICS, NONPARAMETRIC; SYNOVIAL MEMBRANE;

MUS;

EID: 49449111630     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0801898105     Document Type: Article

References (39)

1. Schmitz JA, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479-490.
2. Dinarello CA (2002) The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 20:S1-13.
3. Chackerian AA, et al. (2007) IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 179:2551-2555.
4. Ali S, et al. (2007) IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 104:18660-18665.
5. Xu D, et al. (1998) Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 188:1485-1492.
6. Lohning MA, et al. (1998) T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 95:6930-6935.
7. Walzl G, et al. (2001) Inhibition of T1/ST2 during respiratory syncytial virus infection prevents T helper cell type 2 (Th2)- but not Th1-driven immunopathology. J Exp Med 193:785-792.
8. Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK (2008) IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes. J Immunol 180:2443-2449.
9. Hoshino KS, et al. (1999) The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J Exp Med 190:1541-1548.
10. Senn KA, et al.(2000) T1-deficient and T1-Fc-transgenic mice develop a normal protective Th2-type immune response following infection with Nippostrongylus brasiliensis. Eur J Immunol 30:1929-1938.
11. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN (2000) T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 191:1069-1076.
12. Moritz DR, Rodewald HR, Gheyselinck J, Klemenz R (1998) The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J Immunol 161:4866-4874.
13. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G (2007) Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179:2051-2054.
14. Ho LH, et al. (2007) IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 82:1481-1490.
15. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429-442.
16. Janossy G, et al. (1981) Rheumatoid arthritis: A disease of T-lymphocyte/macrophage immunoregulation. Lancet 2:839-842.
17. Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397-440.
18. Ulfgren AK, Lindblad S, Klareskog L, Andersson J, Andersson U (1995) Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 54:654-661.
19. Kageyama Y, et al. (1998) Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 161:1542-1548.
20. Leung BP, McInnes IB, Esfandiari E, Wei XQ, Liew FY (2000) Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol 164:6495-6502.
21. Chabaud M, et al. (1999) Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963-970.
22. Nakae S, Nambu A, Sudo K, and Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173-6177.
23. Stuart JM, Dixon FJ (1983) Serum transfer of collagen-induced arthritis in mice. J Exp Med 158:378-392.
24. Edwards JC, Cambridge G (2006) B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6:394-403.
25. Edwards JC, et al. (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350:2572-2581.
26. Bromley M, Fisher WD, Woolley DE (1984) Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis 43:76-79.
27. Tetlow LC, Woolley DE (1995) Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis 54:549-555.
28. Lee DM, et al. (2002) Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297:1689-1692.
29. Corr M, Crain B (2002) The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis. J Immunol 169:6604-6609.
30. Moulin D, et al. (2007) Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40:216-225.
31. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203:1685-1691.
32. Bettelli EY, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
33. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942-949.
34. Hitchon CA, et al. (2004) A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol 31:2336-2346.
35. Hitchon CA, El-Gabalawy HS (2002) Immune features of seronegative and seropositive arthritis in early synovitis studies. Curr Opin Rheumatol 14:348-353.
36. Sanada S, et al. (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117:1538-1549.
37. Gracie JA, et al. (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104:1393-1401.
38. Brint, EK, et al. 2004. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5:373-379.
39. Komai-Koma M, et al. (2007) IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37:2779-2786.